MECPROWA Trademark

Trademark Overview

On Thursday, July 31, 2025, a trademark application was filed for MECPROWA with the United States Patent and Trademark Office. The USPTO has given the MECPROWA trademark a serial number of 99312521. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 31, 2025. This trademark is owned by Taysha Gene Therapies, Inc.. The MECPROWA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in the treatment of neurodevelopmental diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in the treatment of Rett syndrome diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in intrathecally administered gene therapy treatments
mecprowa

General Information

Serial Number99312521
Word MarkMECPROWA
Filing DateThursday, July 31, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, July 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceuticals and pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in the treatment of neurodevelopmental diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in the treatment of Rett syndrome diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in intrathecally administered gene therapy treatments

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 31, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTaysha Gene Therapies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 75247

Trademark Events

Event DateEvent Description
Thursday, July 31, 2025NEW APPLICATION ENTERED
Thursday, July 31, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 31, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

mecprowa pharmaceuticals preparations pharmaceutical diseases disorders treatment gene administered therapy treatments